Clicky

Precision BioSciences, Inc.(DTIL)

Description: Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.


Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing Agriculture Solutions

Home Page: www.precisionbiosciences.com

DTIL Technical Analysis

302 East Pettigrew Street
Durham, NC 27701
United States
Phone: 919 314 5512


Officers

Name Title
Mr. Michael Amoroso Pres, CEO & Director
Dr. Derek Jantz Ph.D. Co-Founder, Chief Scientific Officer & Strategy
Mr. John Alexander Kelly Chief Financial Officer
Dr. Jefferson J. Smith Ph.D. Co-Founder & Chief Research Officer
Mr. Shane Barton VP, Corp. Controller & Principal Accounting Officer
Mei Burris Director of Investor Relations & Fin.
Mr. Dario Scimeca Gen. Counsel & Sec.
Mr. Bruce Stevens VP of Quality & Compliance
Ms. Heather King Director of Marketing Communications & PR
Maurissa Messier Sr. Director of Corp. Communications

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.6174
Price-to-Sales TTM: 6.3895
IPO Date: 2019-03-28
Fiscal Year End: December
Full Time Employees: 194
Back to stocks